Ustekinumab therapy for severe interstitial granulomatous dermatitis with arthritis

JAMA Dermatology

Volumn 149, Issue 5, 2013, Pages 626-627

  Leloup, Pauline ^a   Aubert, Hélène ^a   Causse, Sylvie ^a   Goff, Benoît Le ^a   Barbarot, Seb́astien ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; PREDNISONE; USTEKINUMAB;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CELL INFILTRATION; COLLAGEN DEGRADATION; DERMATITIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; ECHOGRAPHY; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL GRANULOMATOUS DERMATITIS; MALE; PAPULE; POLYARTHRITIS; PRIORITY JOURNAL; RASH; RELAPSE; REMISSION; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN MANIFESTATION; TREATMENT DURATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS, RHEUMATOID; DERMATITIS; GRANULOMA; HUMANS; MALE; MIDDLE AGED; SKIN DISEASES;

EID: 84877848532     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.256     Document Type: Article

References (5)

1. Ackerman AB. Histologic diagnosis of inflammatory skin diseases: interstitial granulomatous dermatitis with arthritis. In: Ackerman AB, Jacobson M, Vitale PA, eds. Clues to Diagnosis in Dermatopathology. Vol 3. Chicago, IL: ASCP Press; 1993:309-312.
2. Peroni A, Colato C, Schena D, Gisondi P, Girolomoni G. Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern. Br J Dermatol. 2012;166(4):775-783.
3. Kreuter A, Gambichler T, Altmeyer P. Infliximab therapy for interstitial granulomatous dermatitis. J Eur Acad Dermatol Venereol. 2007;21(2):251-252. (Pubitemid 46128705)
4. Schanz S, Schmalzing M, Guenova E, et al. Interstitial granulomatous dermatitis with arthritis responding to tocilizumab. Arch Dermatol. 2012;148(1):17-20.
5. Judson MA, Marchell RM, Mascelli M, et al. Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway. J Am Acad Dermatol. 2012;66(6):901-910.